{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:30:37Z","timestamp":1786357837245,"version":"build-2736575974"},"reference-count":22,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background\/Objectives: Reliable preoperative assessment of treatment response after neoadjuvant chemoimmunotherapy in locally advanced non-small-cell lung cancer (NSCLC) remains challenging because conventional imaging may not accurately distinguish viable tumour from treatment-related fibrosis or immune-mediated changes. This study investigated whether CT-derived radiomic features combined with machine learning could improve the identification of patients achieving pathological complete response (pCR). Methods: Twenty-nine consecutive patients with stage III NSCLC who underwent surgical resection following neoadjuvant chemoimmunotherapy were retrospectively analysed. Radiomic features were extracted from preoperative CT scans and used to develop supervised machine-learning models based on Random Forest, Support Vector Machine, K-Nearest Neighbors, Multi-Layer Perceptron, and Logistic Regression algorithms. Histopathological findings after surgery served as the reference standard. Feature distributions were compared between patients with and without pCR using the Mann\u2013Whitney U test with Bonferroni correction. Results: Surgical procedures included 19 lobectomies, 2 bilobectomies, 3 pneumonectomies, and 5 complex major resections. Pathological complete response was observed in 9 of 29 patients (31%). The proposed radiomics-based model achieved an area under the ROC curve of 0.92 (95% CI, 0.81\u20131.00), with 91% accuracy, 90% sensitivity, and 92% specificity (p &lt; 0.05). All patients classified by the model as complete responders were confirmed to have pathological complete response at postoperative histological examination. Conclusions: CT-based radiomics combined with machine learning demonstrated promising performance for the preoperative prediction of pathological response after neoadjuvant chemoimmunotherapy in stage III NSCLC. Although these findings require external validation in larger prospective cohorts, this approach may support preoperative treatment assessment and surgical decision-making.<\/jats:p>","DOI":"10.3390\/jcm15166150","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T13:20:16Z","timestamp":1786108816000},"page":"6150","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative CT Radiomics for Assessing Pathological Response to Neoadjuvant Chemoimmunotherapy in Locally Advanced Non-Small-Cell Lung Cancer"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3786-5716","authenticated-orcid":false,"given":"Beatrice","family":"Trabalza Marinucci","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, Sant\u2019Andrea Hospital, Sapienza University, 00189 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8871-5947","authenticated-orcid":false,"given":"Federica","family":"Palmeri","sequence":"additional","affiliation":[{"name":"Department of Radiology, Sant\u2019Andrea Hospital, Sapienza University, 00189 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9285-4764","authenticated-orcid":false,"given":"Damiano","family":"Caruso","sequence":"additional","affiliation":[{"name":"Department of Radiology, Sant\u2019Andrea Hospital, Sapienza University, 00189 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7465-2229","authenticated-orcid":false,"given":"Massimiliano","family":"Mancini","sequence":"additional","affiliation":[{"name":"Department of Morphologic and Molecular Pathology, Sant\u2019Andrea Hospital, Sapienza University, 00189 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Piccioni","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Sant\u2019Andrea Hospital, Sapienza University, 00189 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Messa","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Sant\u2019Andrea Hospital, Sapienza University, 00189 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Ciccone","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Sant\u2019Andrea Hospital, Sapienza University, 00189 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Maurizi","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Sant\u2019Andrea Hospital, Sapienza University, 00189 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erino Angelo","family":"Rendina","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Sant\u2019Andrea Hospital, Sapienza University, 00189 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Sant\u2019Andrea Hospital, Sapienza University, 00189 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"ref_1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa2215530","article-title":"Perioperative Nivolumab and Chemotherapy in Stage III Non\u2013Small-Cell Lung Cancer","volume":"389","author":"Provencio","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/jamaoncol.2022.5389","article-title":"Perioperative immune checkpoint inhibition in early-stage non-small cell lung cancer: A review","volume":"9","author":"Desai","year":"2023","journal-title":"JAMA Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Lin, Q., Wu, H.J., Song, Q.S., and Tang, Y.K. (2022). CT-based radiomics in predicting pathological response in non-small cell lung cancer patients receiving neoadjuvant immunotherapy. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.937277"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"398","DOI":"10.21037\/tcr.2016.06.18","article-title":"Radiomics applied to lung cancer: A review","volume":"5","author":"Scrivener","year":"2016","journal-title":"Transl. Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Pan, F., Feng, L., Liu, B., Hu, Y., and Wang, Q. (2023). Application of radiomics in diagnosis and treatment of lung cancer. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1295511"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00280-017-3396-4","article-title":"Comparison of RECIST to immune-related response criteria in patients with non-small cell lung cancer treated with immune-checkpoint inhibitors","volume":"80","author":"Kim","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Barabino, E., Rossi, G., Pamparino, S., Fiannacca, M., Caprioli, S., Fedeli, A., Zullo, L., Vagge, S., Cittadini, G., and Genova, C. (2022). Exploring Response to Immunotherapy in Non-Small Cell Lung Cancer Using Delta-Radiomics. Cancers, 14.","DOI":"10.3390\/cancers14020350"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Siciliani, A., Guido, G., De Santis, D., Bracci, B., Masci, B., Faggiano, A., Mikovic, N., Paravani, P., Martiradonna, M., and Palmeri, F. (2025). Role of Chest CT Radiomics in Differentiating Tumorlets and Granulomas: A Preliminary Study. J. Clin. Med., 15.","DOI":"10.3390\/jcm15010210"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1148\/radiol.2020191145","article-title":"The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping","volume":"295","author":"Zwanenburg","year":"2020","journal-title":"Radiology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jtho.2023.07.017","article-title":"International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy","volume":"18","author":"Dacic","year":"2023","journal-title":"J. Thorac. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"pkae021","DOI":"10.1093\/jncics\/pkae021","article-title":"Pathological response in resectable non\u2013small cell lung cancer: A systematic literature review and meta-analysis","volume":"8","author":"Quintana","year":"2024","journal-title":"JNCI Cancer Spectr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jtcvs.2026.03.622","article-title":"The 2026 American Association for Thoracic Surgery Expert Consensus Document: Evaluation and management of N2+ non\u2013small cell lung cancer","volume":"172","author":"Linden","year":"2026","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.athoracsur.2025.10.016","article-title":"Clinical Characteristics and Surgical Outcomes of Patients Receiving Perioperative Pembrolizumab in KEYNOTE-671","volume":"121","author":"Liberman","year":"2026","journal-title":"Ann. Thorac. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.1200\/JCO.2024.42.16_suppl.8011","article-title":"Outcomes with perioperative durvalumab (D) in pts with resectable NSCLC and baseline N2 lymph node involvement (N2 R-NSCLC): An exploratory subgroup analysis of AEGEAN","volume":"42","author":"Heymach","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Verma, S., Breadner, D., Mittal, A., Palma, D.A., Nayak, R., Raphael, J., and Vincent, M. (2024). An Updated Review of Management of Resectable Stage III NSCLC in the Era of Neoadjuvant Immunotherapy. Cancers, 16.","DOI":"10.3390\/cancers16071302"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1007\/s00432-020-03360-1","article-title":"Pseudoprogression and hyperprogression in lung cancer: A comprehensive review of literature","volume":"146","author":"Zhou","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","article-title":"Radiomics: Extracting more information from medical images using advanced feature analysis","volume":"48","author":"Lambin","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"101098","DOI":"10.1016\/j.currproblcancer.2024.101098","article-title":"A combined model using pre-treatment CT radiomics and clinicopathological features of non-small cell lung cancer to predict major pathological responses after neoadjuvant chemoimmunotherapy","volume":"50","author":"Wang","year":"2024","journal-title":"Curr. Probl. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/14737140.2021.1852935","article-title":"Radiomics features as predictive and prognostic biomarkers in NSCLC","volume":"21","author":"Bortolotto","year":"2021","journal-title":"Expert Rev. Anticancer Ther."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6150\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T09:48:28Z","timestamp":1786355308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":22,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcm15166150"],"URL":"https:\/\/doi.org\/10.3390\/jcm15166150","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]}}}